Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes.

Autor: Wang, Yan-Hua1 (AUTHOR), Hagiwara, Shotaro1 (AUTHOR), Kazama, Hiroshi1,2 (AUTHOR), Iizuka, Yuki1 (AUTHOR), Tanaka, Norina1 (AUTHOR), Tanaka, Junji1 (AUTHOR)
Zdroj: Journal of Immunology Research. 2/27/2024, Vol. 2024, p1-18. 18p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje